Cyclophosphamide monohydrate
6055-19-2
Industrial Grade
99%
beijing；shanghai
shandong boyuan
25kg/Cardboard Drum
2024-11-30
Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Cyclophosphamide monohydrate
Other Name:2H-1,3,2-Oxazaphosphorin-2-amine,N,N-bis(2-chloroethyl)tetrahydro-,2-oxide,hydrate (1:1);2H-1,3,2-Oxazaphosphorine,2-[bis(2-chloroethyl)amino]tetrahydro-,2-oxide,monohydrate;2H-1,3,2-Oxazaphosphorin-2-amine,N,N-bis(2-chloroethyl)tetrahydro-,2-oxide,monohydrate;2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate;Cyclophosphamide monohydrate;Endoxan monohydrate;Cyclophosphamide hydrate
CAS No.:6055-19-2
Molecular Formula:C7H15Cl2N2O2P.H2O
InChIKeys:InChIKey=PWOQRKCAHTVFLB-UHFFFAOYSA-N
Molecular Weight:279.1
Exact Mass:278.035370
BRN:8167897
EC Number:200-015-4
UN Number:2811
DSSTox ID:DTXSID6024888
HScode:2934999090
Categories:
Characteristics-
PSA:
42.6
XLogP3:2.14850
Appearance:White to almost white Crystals or Crystalline Powder
Melting Point:41-45 °C
Boiling Point:336.1ºC at 760 mmHg
Flash Point:>230 °F
Water Solubility:H2O: 40 g/L
Storage Conditions:2-8°C
Collision Cross Section:146.5 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Air and Water Reactions:Water soluble. Sensitive to moisture and light. Aqueous solutions may be kept for a few hours above room temperature, but hydrolysis occurs at temperatures above 86°F. It undergoes both specific acid and specific base catalysis at extreme pHs. Spontaneous hydrolysis in aqueous solutions.
Reactive Group:Amines, Phosphines, and Pyridines
Reactivity Profile:Polymerization can occur at temperatures > 120° F. CYCLOPHOSPHAMIDE MONOHYDRATE reacts with strong oxidizing agents, strong acids and strong bases. Benzyl alcohol increases rate of hydrolysis. (NTP, 1992)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Serious eye damage, Category 1
Germ cell mutagenicity, Category 1A
Carcinogenicity, Category 1A
Reproductive toxicity, Category 1A
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H318 Causes serious eye damage
H340 May cause genetic defects
H350 May cause cancer
H360 May damage fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
H413 May cause long lasting harmful effects to aquatic life
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib
-
Location:
NO.28 SangYuan Rd,JinanCity,ShanDong Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
501-1000
-
Year of Establishment:
2005
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
